MedTrace Logo

Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers

NCT01639716 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2012-07-13

No results posted yet for this study

Summary

The investigators hypothesized that Non Hodgkin lymphoma is using T helper 2 pathways. So that the investigators decided to study of cytokines related to T helper 2 pathways. It is well known that parasites and allergic situations also use T helper 2 pathways. Because that the investigators excluded the patients have parasites and allergic situations. All the patients were over 18. The investigators included the patients with non Hodgkin lymphoma which new diagnosed. It is observational study. The investigators took blood before chemotherapy and four months later. The investigators did not interfere with which chemotherapy will be given to patients. This decision was belong to hematologist or oncologist who will treat the patient.

Conditions

Sponsors & Collaborators

  • Nil Guler

    lead INDIV

Principal Investigators

  • Nil Guler, MD

  • Nil Guler, MD · ONDOKUZ MAYİS UNİVERSİTY, SCHOOL OF MEDİCİNE

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-05-31
Completion
2012-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01639716 on ClinicalTrials.gov